ChinaXiv has partnered with F1000 and Taylor&Francis Publishing Group to jointly support and promote preprint exchange, providing an efficient channel for authors of papers submitted to ChinaXiv for publication. At present, researchers in ChinaXiv cloth preprints can initiate synchronous submissions to a series of journals under Taylor&Francis Publishing Group and Dove Medical Press, including Annals of Medicine (2022 Impact Factor 4.4), and receive multiple conveniences and benefits.
1、 What benefits can the author gain?
By combining the comprehensive expertise of F1000 and Taylor&Francis, we can support you in quickly sharing your research findings with the international research community while waiting for peer review and publication. Authors participating in this pilot project will have the opportunity to participate in open research activities and gain the following benefits:
(1) After being peer-reviewed by ChinaXiv preprints, submissions can be quickly published in Annals of Medicine or Defu Medical Press journals.
(2) By keeping early records of research sources, prevent others from publishing or using your research results first.
(3) During the waiting period for publication, allow other researchers to conduct research on your basis and cite your findings.
(4) In the process of continuous deepening of research, revised versions will be released to demonstrate the progress of the research.
(5) By disclosing information on ongoing and planned research, avoid duplicate research in the field.
(6) Build your publishing record and research reputation by publishing work in multiple formats such as protocols, case series, or comments, and publishing negative and invalid results.
(7) Obtaining rigorous and constructive feedback: Due to the increasing visibility and transparency of the open peer review process, authors typically receive more comprehensive, rigorous, and constructive improvement suggestions to improve research quality.
(8) Motivating constructive collaboration: By publishing a complete review report, you can engage in constructive dialogue with reviewers and readers worldwide.
(9) Maintain research integrity: The peer review process is fully open, and reviewers are responsible for the author's research feedback, reducing the possibility of bias or conflicts of interest.
2、 How does the preprint platform run?
Unlike traditional journal submissions, your submission will follow an open peer review model, and all comments and versions will be made public on ChinaXiv. The F1000 Open Publishing Platform has over 12 years of successful management experience in interdisciplinary open peer review, and collaborates with numerous major funders, institutions, and associations worldwide, including the Wellcome Foundation, the Bill and Melinda Gates Foundation, and the European Commission.
3、 Preparation before submission
Step 1: The author needs to publish the paper on ChinaXiv（ https://chinaxiv.org ）On the preprint platform;
Step 2: The author needs to scan the following QR code and fill out and submit a simple submission form online;
Scan the QR code below to access the submission form
Step 3: After receiving the form content submitted by the author online, the journal editorial department will send an email to the author. The author submitted the manuv 4、 Collaborating journals for this project
1. International Journal of Nanomedicine
(2023 Impact Factor 6.6)
Journal website: https://www.tandfonline.com/journals/dijn20
2. Annals of Medicine
(Note: The journal currently only accepts research papers in the field of oncology from this pilot project, with an impact factor of 4.9 in 2023)
Journal website: https://www.tandfonline.com/journals/iann20
3. Journal of Inflammation Research (2023 Impact Factor 4.2)
Journal website: https://www.tandfonline.com/journals/djir20
4. Break Cancer: Targets and Therapy (2023 Impact Factor 3.3)
Journal website: https://www.tandfonline.com/journals/dbct20
5. Clinical Pharmacy: Advancements and Applications (2023 Impact Factor 3.1)
Journal website: https://www.tandfonline.com/journals/dcpa20
6. International Journal of Nephrology and Renovascular Disease (2023 Impact Factor 2.1)
Journal website: https://www.tandfonline.com/journals/dnrd20
7、Integrated Pharmacy Research and Practice （2023 Impact Factor2.1）
期刊网址：https://www.tandfonline.com/journals/dipr20
8、Patient Preference and Adherence （2023 Impact Factor2.1）
期刊网址：https://www.tandfonline.com/journals/dppa20
9. Nursing: Research and Reviews (2023 Impact Factor 0.8)
Journal website: https://www.tandfonline.com/journals/dnrr20
10、Pharmacogenomics and Personalized Medicine （2023 Impact Factor）
Journal website：https://www.tandfonline.com/journals/dpgp20
11、Journal of Experimental Pharmacology (2023 CiteScore (Scopus)7.4）
Journal website：https://www.dovepress.com/journal-of-experimental-pharmacology-journal
What is a preprint
The Characteristics of Preprints
FAQs
Enhance the visibility of your research
Enhance the impact of your research
